trending Market Intelligence /marketintelligence/en/news-insights/trending/rKhSarYdKzqiXUdyAxlOwA2 content esgSubNav
In This List

Chugai Pharmaceutical names CEO

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Chugai Pharmaceutical names CEO

Tatsuro Kosaka will become the CEO of Chugai Pharmaceutical Co. Ltd. at the end of March 2018, replacing Osamu Nagayama.

Nagayama will assume the responsibilities of board chairman and representative director.

Kosaka currently serves as a representative director, president and COO of the company.